Novo Nordisk AS (HAM:NOVA)
€ 41.8 -0.20 (-0.48%) Market Cap: 185.04 Bil Enterprise Value: 201.74 Bil PE Ratio: 11.60 PB Ratio: 6.95 GF Score: 81/100

Q2 2019 Novo Nordisk A/S Earnings Presentation Transcript

Aug 12, 2019 / 12:15PM GMT

Aug 12, 2019 / 12:15PM GMT
Presentation
Aug 12, 2019 / 12:15PM GMT

=====================
Corporate Participants
=====================
* Karsten Munk Knudsen
Novo Nordisk A/S - Executive VP & CFO
* Lars Fruergaard Jørgensen
Novo Nordisk A/S - President & CEO
* Mads Krogsgaard Thomsen
Novo Nordisk A/S - Executive VP & Chief Science Officer

=====================
Conference Call Participants
=====================
* James Patrick Quigley
JP Morgan Chase & Co, Research Division - Analyst
* Jo Walton
Crédit Suisse AG, Research Division - MD
* Keyur Parekh
Goldman Sachs Group Inc., Research Division - Equity Analyst
* Mark Douglas Purcell
Morgan Stanley, Research Division - Equity Analyst
* Michael Leuchten
UBS Investment Bank, Research Division - Co-Head of Pharmaceuticals Research of Equity Research
* Sachin Jain
BofA Merrill Lynch, Research Division - MD
* Wimal Kapadia
Sanford C. Bernstein & Co., LLC., Research Division - Research

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot